Corporate Strategy for a Biotech Company with a Diversified Portfolio

Publications May 25, 2023

The EU Pharmaceutical Package: Introduction to Changes

Alira Health’s Regulatory experts explore how the proposed package will disrupt the European regulatory landscape and what it means for companies.

EU Pharma Regulatory

Events May 16, 2023

PSI 2023 Conference

We're excited to talk orphan drugs and rare diseases at the World Orphan Drug Congress in Washington, D.C.

Orphan Drug Pharma Rare Disease UK

Events May 15, 2023

World Orphan Drug Congress USA

We're excited to talk orphan drugs and rare diseases at the World Orphan Drug Congress in Washington, D.C.

Orphan Drug Pharma Rare Disease

Events May 15, 2023

BIO International Convention

We are excited to share that we will be attending the BIO International Convention in Boston. This leading industry event attracts biotechnology and pharma leaders for one week of intensive(...)

Biotech Pharma

Blog April 17, 2023

Reimbursement of Rare Disease Drugs in Italy: Challenges and Hopes for the Future

When it comes to rare diseases, Italy has done a good job in bringing EMA-approved drugs, including orphan drugs, to the Italian market. But  multiple challenges exist, many of which(...)

Italy Market Access Pharma Rare Disease Real-World Evidence (RWE)

Blog April 17, 2023

Pharmaceutical Market Access in the UK: A Changing Landscape

Start reading this interview with Rachel Fyson to gain insight into the changing landscape of market access in the United Kingdom.

Market Access Pharma UK

Blog April 14, 2023

Lifecycle Optimization: The Path to Commercial Success

Pharmaceutical and biotech companies constantly focus on product innovation. But how can you also increase your effectiveness in order to be as commercially competitive and efficient as possible?

Market Access MedTech Pharma